Sertraline-associated bruxism

Canadian Journal of Clinical Pharmacology

Volumn 3, Issue 3, 1996, Pages 123-125

  Por, Choo Pin ^a   Watson, Lynn ^b   Doucette, Doug ^b   Dolovich, Lisa ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Bruxism; Jaw clenching; Selective serotonin reuptake inhibitors (SSRI); Sertraline; Teeth grinding

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGED; ARTICLE; BRUXISM; CASE REPORT; CLINICAL FEATURE; DEPRESSION; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

EID: 0029909570     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Finley PR. Selective serotonin reuptake inhibitors: Pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 1994;28:1359-69.
2. Faulkner KDB. Bruxism: A review of the literature. Part 1. Aust Dent J 1990;35:266-76.
3. Thompson BA, Blount BW, Krumholz T. Treatment approaches to bruxism. Am Fam Physician 1994;49:1617-22.
4. Ellison JEM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry 1993;54:432-4.
5. Chong SA. Fluvoxamine and mandibular dystonia. Can J Psychiatry 1995;40:430-1.
6. Hansten PD, Horn JR, eds. Drug Interactions and Updates. Vancouver: Applied Therapeutics Inc, 1996.
7. Tatros DS, ed. Drug Interaction Facts, Facts and Comparisons. St Louis: Facts and Comparisons Inc, 1996.
8. Naranjo CA, Busto U, Seller EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;20:239-45.
9. Lane R, Balwin D, Preskorn S. The SSRIS: Advantages, disadvantages and differences. J Psychopharm 1995;9(Suppl):163-78.
10. Murdoch D, McTavish D. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 1992;44:604-24.